Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells Jian-ping ZouJun ShimizuToshiyuki Hamaoka Original articles Pages: 1 - 6
Effector molecules from antitumor macrophages induced with OK-432 and cyclophosphamide Kazuo Ryoyama Original articles Pages: 7 - 13
Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β M. Rita I. YoungMark A. WrightJamila Bagash Original articles Pages: 14 - 18
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody Chi-Yu Gregory LeeKuang-Wei ChenHeung-Tat Ng Original articles Pages: 19 - 26
Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases Paola ZanovelloAntonio RosatoDino Collavo Original articles Pages: 27 - 32
Seroreactivity to HPV-16 proteins in women with early cervical neoplasia Shannon R. BarberJohn WerdelChristopher P. Crum Original articles Pages: 33 - 38
Induction of antitumor activities in spleen cells from mice and rats activated with lipopolysaccharide immobilized on beads Hajime AbeTohru TaniMasashi Kodama Original articles Pages: 39 - 45
The loss of class II MHC antigen expression byras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells Alan G. MorrisRichard L. DarleyWendy J. Bateman Original articles Pages: 46 - 52
Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: Effect on natural cytotoxicity K. G. M. ParkS. D. HeysO. Eremin Original articles Pages: 53 - 58
GD3-reactive antibodies can inhibit the lysis of autologous tumor cells by tumor-infiltrating lymphocytes Edward B. ReillyGiovanna Antognetti Original articles Pages: 59 - 62
Chemo-Immunotherapy of murine solid tumors: Enhanced therapeutic effects by interleukin-2 combined with interferon α and the role of specific T cells Eli KedarYaron RutkowskiBenny Leshem Original articles Pages: 63 - 68
Photo-immunotargeting with haematoporphyrin conjugates activated by a low-power He-Ne laser Timea BerkiPéter Németh Original articles Pages: 69 - 74